In the short-term 51Cr release assay, only pre-activated γδ-T cells, stimulated with either pp65 or CD40L/pp65_APCs showed activity against the ALL-B CD19+-Daudi cells, but not against allogeneic B-cells (aCD19+). This evidence concerns the gene CD40LG and acute lymphoblastic leukemia.